Women's 50+ Multi Greens
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 249.9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 39.9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.9 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 39.9 mg a day according to the dosing instructions published by Health Canada, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (12 mg a day). The EFSA reference covers total daily intake, from food and supplements.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada, above the safe level from EFSA for adults (8 mg a day). Exceeding it does not, on its own, characterise a risk: EFSA could not set an upper limit for this nutrient. The EFSA reference covers total daily intake, from food and supplements.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Aphanizomenon flos-aquae Ralfs ex Bornet & Flahault: Les préparations de cette plante sont seulement autorisées s'il peut être démontré par des rapports d'analyse qu'elles ne contiennent pas de microcystine (< 1µg/g) et d'autres toxines marines.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 9,200 microgrammes Potency : 40 % Epigallocatechin 3-gallate | 460 microgrammes | Not calculated |
| Camellia sinensis Source : Feuille Potency : 60 % Catechins | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 15 % Caffeine | Not specified | Not calculated |
| Boron Source : Citrate de bore | 1 milligramme | Not calculated |
| Euterpe oleracea Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1,200 microgrammes | 300 microgrammes | Not calculated |
| Riboflavine Source : Riboflavin 5'-phosphate de sodium | 5 milligramme | 15,000 µg |
| Vaccinium corymbosum Source : Vaccinium corymbosum - Fruit | 16.6 milligramme | Not calculated |
| Brassica oleracea var. italica Source : Sommité | 770 microgrammes | Not calculated |
| Phyllanthus emblica Source : Fruit Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 7,500 microgrammes | 150 microgrammes | Not calculated |
| Schisandra chinensis Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 6,000 microgrammes | 300 microgrammes | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 8 milligramme | 24,000 µg |
| Thiamine Source : Benfotiamine | 8 milligramme | 24,000 µg |
| Vitamine C Source : Calcium ascorbate dihydrate | 83.3 milligramme | 249,900 µg |
| Solanum lycopersicum Source : Solanum lycopersicum - fruit | 1,540 microgrammes | Not calculated |
| Aphanizomenon flos-aquae Source : En entier Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 6,160 microgrammes | 1,540 microgrammes | Not calculated |
| Beta vulgaris Source : Racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 12,320 microgrammes | 1,540 microgrammes | Not calculated |
| Choline Source : Bitartrate de choline | 13.3 milligramme | Not calculated |
| Magnésium Source : Oxyde de magnésium | 33.3 milligramme | 99,900 µg |
| Magnésium Source : Bisglycinate de magnésium | 33.3 milligramme | 99,900 µg |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 11,500 microgrammes | 460 microgrammes | Not calculated |
| Calcium Source : Citrate de calcium | 76.6 milligramme | 229,800 µg |
| Calcium Source : Carbonate de calcium | 76.6 milligramme | 229,800 µg |
| Sélénium Source : Sélénométhionine | 33.3 microgrammes | Not calculated |
| Medicago sativa Source : Sommité | 15,400 microgrammes | Not calculated |
| Mangifera indica Source : Fruit | 1,540 microgrammes | Not calculated |
| Molybdène Source : Citrate de molybdène (VI) | 13.3 microgrammes | Not calculated |
| Niacine Source : Hexanicotinate d'inositol | 8.3 milligramme | Not calculated |
| Niacinamide Source : Niacinamide | 8.3 milligramme | Not calculated |
| Acide pantothénique Source : D-Pantéthine | 16.6 milligramme | 49,800 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 16.6 milligramme | 49,800 µg |
| Papaïne Source : Carica papaya - fruit | 504 Unités de papaïne du FCC | Not calculated |
| Papaïne Source : Carica papaya - fruit | 84 microgrammes | Not calculated |
| Pectine Source : Malus domestica - Fruit | 9,250 microgrammes | Not calculated |
| Potassium Source : Citrate de potassium | 6.6 milligramme | 19,800 µg |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 650 milligramme Potency : 80 % Oligomeric proanthocyanidins | 6.5 milligramme | Not calculated |
| Silybum marianum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 13,800 microgrammes | 460 microgrammes | Not calculated |
| Spinacia oleracea Source : Feuille | 3,080 microgrammes | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 2,520 Unités de papaïne du FCC | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 168 microgrammes | Not calculated |
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 3,080 microgrammes | 770 microgrammes | Not calculated |
| Triticum aestivum Source : Sommité | 770 microgrammes | Not calculated |
| Vanadium Source : Produit de chélation de vanadium et de protéine végétale hydrolysée (PVH) | 16.6 microgrammes | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 500 mcg EAR | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 1,655 UI | Not calculated |
| Vitamine B12 Source : Cobamamide | 83.2 microgrammes | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 83.2 microgrammes | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 13.3 milligramme | 39,900 µg |
| Vitamine D Source : Cholécalciférol | 8.3 microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 332 UI | 24.9 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 33.5 mg AT | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 50 UI | Not calculated |
| Vitamin K2 Source : Vitamin K2 | 6.6 microgrammes | Not calculated |
| Zinc Source : Citrate de zinc | 5 milligramme | 15,000 µg |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 1.6 milligramme | Not calculated |
| 1-Carboxy-N,N,N-trimethylmethanaminium inner salt Source : Chlorhydrate de bétaine | 7,728 microgrammes | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 0.84 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 168 microgrammes | Not calculated |
| Ananas comosus var. comosus Source : Fruit Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 18,480 microgrammes | 1,540 microgrammes | Not calculated |
| Apium graveolens Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 3,080 microgrammes | 770 microgrammes | Not calculated |
| Arthrospira platensis Source : En entier | 1,540 microgrammes | Not calculated |
| bêta-carotène Source : bêta-carotène | 1,000 microgrammes | Not calculated |
| bêta-carotène Source : bêta-carotène | 1,667 UI | Not calculated |
| Biotine Source : Biotine | 33.3 microgrammes | Not calculated |
| Carica papaya Source : Fruit | 21.8 microgrammes | Not calculated |
| Chrome Source : Nicotinate de chrome (III) | 133.3 microgrammes | Not calculated |
| Citrus sinensis Source : Fruit Extract : Matériel brut sec Extraction ratio : 210:1 Dry plant equivalent : 31,500 microgrammes | 150 microgrammes | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 500 microgrammes | Not calculated |
| Cynara cardunculus Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 12,320 microgrammes | 1,540 microgrammes | Not calculated |
| Eleutherococcus senticosus Source : Racine Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 6,900 microgrammes | 460 microgrammes | Not calculated |
| Folate Source : Acide L-5 méthyltétrahydrofolique, sel de glucosamine | 200 microgrammes | Not calculated |
| Mélange de fruits Source : rubus idaeus - fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Vaccinium myrtillus - Fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Vaccinium corymbosum - Fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Fragaria vesca - Fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Vitis vinifera - Fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Vaccinium macrocarpon- fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Mélange de fruits Source : Punica granatum, Fruit Potency : 76 % Polyphenols | 3,080 microgrammes | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 23,000 microgrammes Potency : 24 % Flavonoid glycosides | 460 microgrammes | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| 3-hydroxyméthylindole Source : Indole-3-carbinol | 1.6 milligramme | Not calculated |
| Inositol Source : Hexanicotinate d'inositol | 15.3 milligramme | Not calculated |
| Inositol Source : Inositol | 15.3 milligramme | Not calculated |
| Iode Source : Iodure de potassium | 166.6 microgrammes | Not calculated |
| Fer Source : Fumarate de fer (II) | 29 microgrammes | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 3 milligramme | 9,000 µg |
Non-medicinal ingredients
Algues d'Eucheuma traitées, Réglisse séchée, Feuille de stevia rebaudiana, Extrait de son d'Oryza sativa (Riz), Acid citrique, Poudre d'enveloppes d'Oryza sativa (Riz), Chlorophyllin Copper Complex, Stéarate de magnésium, Mélange de légumes, Cellulose microcristalline, Carbohydrate gum, Poudre de bulbe d'ail, silice, Eau purifiée, Gomme arabique, Kelp Extract, Huile de tournesol, Chlorella Vulgaris biomass
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamins and minerals, factors in the maintenance of good health. Source of vitamins and minerals, factors in normal growth and development. Source of vitamins and minerals, to support biological functions which play a key role in the maintenance of good health. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that protects the fat in body tissues from oxidation. Source of/An antioxidant that helps protect against oxidative stress. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in wound healing. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to prevent vitamin C deficiency. Helps to maintain the body's ability to metabolize nutrients. Helps in energy metabolism and in tissue formation. Helps to prevent pantothenic acid deficiency. Helps to form red blood cells. Helps to prevent vitamin B6 deficiency. Helps in energy production. Helps to prevent thiamine deficiency. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps to prevent riboflavin deficiency. Helps to prevent vitamin B3 deficiency. Provitamin A for the maintenance of good health. Provitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of bones and teeth. Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision.
Helps to build strong bones and teeth. Helps to prevent vitamin A deficiency. Helps in the normal function of the immune system. Helps in energy metabolism in the body. Helps to prevent vitamin B12 deficiency. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain cognitive functions. Helps to prevent biotin deficiency. Helps to prevent vitamin E deficiency. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps in the process of normal cell division. Helps to prevent vitamin D deficiency. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life).Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Source of/An electrolyte for the maintenance of good health. Helps to maintain normal muscle function. Helps in the process of normal regulation of cell division and specialization. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain normal electrolyte balance. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin. Helps to prevent zinc deficiency. Helps to prevent manganese deficiency. Helps to produce and repair connective tissue. Helps to maintain normal iron transport in the body. Helps to prevent copper deficiency. Helps maintain healthy calcium metabolism. Helps in the function of the thyroid gland. Helps to maintain normal production of thyroid hormones. Helps to prevent iodine deficiency. Provides support for healthy glucose metabolism. Helps to maintain normal blood glucose levels. Helps to prevent chromium deficiency. Helps to maintain normal function of the thyroid gland. Helps to prevent selenium deficiency. Digestive enzyme. Source of antioxidants/Provides antioxidants. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to support liver function. A factor in the maintenance of good health. Helps to prevent folate deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Multi Greens, Multi Greens Women 50+, Multi with greens, Multis Women¿s 50+, Preferred Nutrition Multi Greens, Preferred Nutrition Multi Greens Women 50+, VitaDay Multi Greens, VitaDay Multi Greens Women 50+
- Licence holder
- Assured Natural Distribution Inc.
- NPN or DIN-HM
- 80081588
- Status
- Active licence
- Licence date
- 30 November 2017
- Revision date
- 4 June 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80081588
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Euterpe oleracea
Read the warning, when it applies and the studies cited
ACAI – EUTERPE OLERACEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
- Vaccinium corymbosum
Read the warning, when it applies and the studies cited
Blueberry
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).
Sources cited by Health Canada (4)
- ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
- Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Randomised trial
- Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
- IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.
- Phyllanthus emblica
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Medicago sativa
Read the warning, when it applies and the studies cited
ALFALFA - MEDICAGO SATIVA
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
- Silybum marianum
Read the warning, when it applies and the studies cited
MILK THISTLE - SILYBUM MARIANUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).
Sources cited by Health Canada (2)
- Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
- Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).
- Vitamine D
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Sources cited by Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- Cynara cardunculus
Read the warning, when it applies and the studies cited
Globe Artichoke - Cynara Cardunculus
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones (Brinker 2010; Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Condition of application: Digestive disturbance/dyspepsia/Help increase bile flow.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you have a bile duct obstruction (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), March 27, 2018. [Accessed 2025 December 30]. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cynara-cardunculus-l-syn-cynara-scolymus-l-folium_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), March 27, 2018. [Accessed 2025 December 30]. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cynara-cardunculus-l-syn-cynara-scolymus-l-folium_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Eleutherococcus senticosus
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Ginkgo biloba
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Women's 50+ Multi Greens”, https://compoatlas.com/en/supplements/canada/80081588-women-s-50-multi-greens, updated 4 June 2018.